However, Yue et al. [31] reported that ALKBH5 was overexpression in intestinal metaplasia (IM) tissues compared with adjacent normal gastric tissues, which may be a potential preventive and therapeutic strategy for gastric IM in GC patients. This evidence concerns the gene ALKBH5 and gastric cancer.